General MedicationsINJECTIONStandard
DOXORUBICIN HYDROCHLORIDE
DOXORUBICIN HYDROCHLORIDE
Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208888 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor AMNEAL Submission history Latest submission status date: 2023-07-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 208888 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 50MG/VIAL Sponsor AMNEAL Submission history Latest submission status date: 2023-07-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.